Cargando…
Correction to: Targeted therapy against Bcl-2-related proteins in breast cancer cells
Autores principales: | Emi, Manabu, Kim, Ryungsa, Tanabe, Kazuaki, Uchida, Yoko, Toge, Tetsuya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6378715/ https://www.ncbi.nlm.nih.gov/pubmed/30773141 http://dx.doi.org/10.1186/s13058-019-1105-4 |
Ejemplares similares
-
Targeted therapy against Bcl-2-related proteins in breast cancer cells
por: Emi, Manabu, et al.
Publicado: (2005) -
Correction: BCL-XL is an actionable target for treatment of malignant pleural mesothelioma
por: Arulananda, Surein, et al.
Publicado: (2021) -
Current and Future Therapies for Immunogenic Cell Death and Related Molecules to Potentially Cure Primary Breast Cancer
por: Kim, Ryungsa, et al.
Publicado: (2021) -
Correction to: Bcl-2/Bcl-xL inhibitor ABT-263 overcomes hypoxia-driven radioresistence and improves radiotherapy
por: Ritter, Violetta, et al.
Publicado: (2022) -
Author Correction: Viral Bcl2s’ transmembrane domain interact with host Bcl2 proteins to control cellular apoptosis
por: García-Murria, Maria Jesús, et al.
Publicado: (2021)